Cambridge Investment Research Advisors’s TriplePoint Venture Growth BDC TPVG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,852
Closed -$68K 3961
2025
Q3
$68K Sell
11,852
-400
-3% -$2.66K ﹤0.01% 3633
2025
Q2
$86K Sell
12,252
-880
-7% -$5.77K ﹤0.01% 3484
2025
Q1
$92K Buy
13,132
+1,833
+16% +$14K ﹤0.01% 3359
2024
Q4
$83K Sell
11,299
-14,494
-56% -$107K ﹤0.01% 3342
2024
Q3
$182K Sell
25,793
-1,082
-4% -$8.44K ﹤0.01% 3181
2024
Q2
$216K Sell
26,875
-3,332
-11% -$30.5K ﹤0.01% 2968
2024
Q1
$286K Buy
30,207
+4,133
+16% +$43.8K ﹤0.01% 2736
2023
Q4
$283K Buy
26,074
+2,971
+13% +$30.4K ﹤0.01% 2640
2023
Q3
$242K Sell
23,103
-63
-0.3% -$719 ﹤0.01% 2670
2023
Q2
$273K Sell
23,166
-244
-1% -$2.76K ﹤0.01% 2617
2023
Q1
$283K Buy
23,410
+490
+2% +$5.72K ﹤0.01% 2541
2022
Q4
$239K Buy
+22,920
New +$277K ﹤0.01% 2620

Other funds holding TPVG

Cambridge Investment Research Advisors's TPVG Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of TriplePoint Venture Growth BDC (TPVG) in Q4 2025, closing a stake of 11,852 shares — an estimated $68K sold.

Cambridge Investment Research Advisors first reported a position in TPVG in Q4 2022 and held it in 12 quarters. The position peaked at $286K in Q1 2024. 75 funds tracked by Wall St. Rank hold TPVG as of Q4 2025.

  • Cambridge Investment Research Advisors reported no remaining TriplePoint Venture Growth BDC position as of Q4 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,852 TriplePoint Venture Growth BDC shares in Q4 2025, an estimated $68K.
  • Cambridge Investment Research Advisors first reported a position in TriplePoint Venture Growth BDC in Q4 2022 and held it in 12 quarters.
  • Cambridge Investment Research Advisors's TriplePoint Venture Growth BDC position peaked at $286K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held TriplePoint Venture Growth BDC as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.